Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Non-cash Items (2022 - 2025)

Biote (BTMD) has 4 years of Non-cash Items data on record, last reported at $5.1 million in Q3 2025.

  • For Q3 2025, Non-cash Items rose 54.83% year-over-year to $5.1 million; the TTM value through Sep 2025 reached $5.1 million, up 54.83%, while the annual FY2024 figure was $3.3 million, 1064.25% up from the prior year.
  • Non-cash Items reached $5.1 million in Q3 2025 per BTMD's latest filing, up from $4.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $5.1 million in Q3 2025 and bottomed at $68925.0 in Q1 2023.
  • Average Non-cash Items over 4 years is $2.0 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Non-cash Items: soared 1738.31% in 2024, then skyrocketed 54.83% in 2025.
  • A 4-year view of Non-cash Items shows it stood at $131461.0 in 2022, then soared by 117.14% to $285459.0 in 2023, then surged by 1064.25% to $3.3 million in 2024, then surged by 52.61% to $5.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $5.1 million in Q3 2025, $4.9 million in Q2 2025, and $3.8 million in Q1 2025.